FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19436411000001101: Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Aug 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65640001000001110 Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112440701000001113 Revocon 25mg tablets (Sun Pharmaceutical Industries Europe B.V.) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Is a Product containing precisely tetrabenazine 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Has active ingredient Tetrabenazine false Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Has specific active ingredient Tetrabenazine true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Is a Revocon true Inferred relationship Existential restriction modifier
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) 112 tablet Has AMP True Revocon 25mg tablets (Sun Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start